S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Biden To Unleash "Choke Point" Operation On America? (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Biden To Unleash "Choke Point" Operation On America? (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The "King Of Quants" sees 10X potential... (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Biden To Unleash "Choke Point" Operation On America? (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Biden To Unleash "Choke Point" Operation On America? (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The "King Of Quants" sees 10X potential... (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Biden To Unleash "Choke Point" Operation On America? (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Biden To Unleash "Choke Point" Operation On America? (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The "King Of Quants" sees 10X potential... (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Biden To Unleash "Choke Point" Operation On America? (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Biden To Unleash "Choke Point" Operation On America? (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The "King Of Quants" sees 10X potential... (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:CMPX

Compass Therapeutics - CMPX Insider Trading & Ownership

$3.27
+0.08 (+2.51%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.20
▼
$3.29
50-Day Range
$3.14
▼
$4.21
52-Week Range
$1.25
▼
$5.65
Volume
199,708 shs
Average Volume
279,912 shs
Market Capitalization
$413.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.05

Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
29.80%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$2.61 M
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$62,561.23

CMPX Insider Buying and Selling by Quarter

Get CMPX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Compass Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2023Thomas J SchuetzCEOBuy10,000$3.37$33,700.006,021,873  
2/27/2023Thomas J SchuetzCEOBuy20,000$3.98$79,600.006,011,873  
2/15/2023Thomas J SchuetzCEOBuy20,000$3.86$77,200.005,991,873  
1/31/2023Thomas J SchuetzCEOBuy20,000$4.05$81,000.005,471,873  
1/24/2023Thomas J SchuetzCEOBuy20,000$4.19$83,800.005,451,873  
11/25/2022Vered Bisker-LeibCOOSell2$4.36$8.721,060,414  
11/22/2022Vered Bisker-LeibCOOSell14,929$4.19$62,552.511,069,985  
11/8/2022Orbimed Advisors LlcDirectorBuy402,000$3.21$1,290,420.0015,219,994  
9/28/2022Thomas J SchuetzCEOBuy10,000$2.32$23,200.005,431,873  
9/26/2022Thomas J SchuetzCEOBuy15,000$2.27$34,050.005,421,873  
8/10/2022Thomas J SchuetzCEOBuy15,000$2.64$39,600.005,361,873  
8/1/2022Thomas J SchuetzCEOBuy15,000$2.58$38,700.005,346,873  
6/21/2022Thomas J SchuetzCEOBuy20,000$2.80$56,000.005,331,873  
6/16/2022Thomas J SchuetzCEOBuy20,000$2.34$46,800.005,311,873  
6/13/2022Thomas J SchuetzCEOBuy30,000$2.29$68,700.005,291,873  
6/6/2022Thomas J SchuetzCEOBuy30,000$2.83$84,900.005,261,873  
6/1/2022Thomas J SchuetzCEOBuy20,000$3.03$60,600.005,231,873  
5/26/2022Thomas J SchuetzCEOBuy20,000$3.04$60,800.005,211,873  
5/23/2022Thomas J SchuetzCEOBuy18,355$2.72$49,925.605,191,873  
5/13/2022Carl L GordonDirectorBuy30,722$2.49$76,497.7814,817,994  
5/11/2022Carl L GordonDirectorBuy64,700$1.79$115,813.0014,690,178  
5/10/2022Thomas J SchuetzCEOBuy27,836$1.80$50,104.805,153,303  
5/9/2022Orbimed Advisors LlcDirectorBuy90,712$1.56$141,510.7214,601,031  
5/6/2022Orbimed Advisors LlcDirectorBuy10,200$1.63$16,626.0014,510,319  
(Data available from 1/1/2013 forward)












CMPX Insider Trading Activity - Frequently Asked Questions

Who is on Compass Therapeutics's Insider Roster?

The list of insiders at Compass Therapeutics includes Carl L Gordon, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX.

What percentage of Compass Therapeutics stock is owned by insiders?

29.80% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings.

Which Compass Therapeutics insiders have been buying company stock?

The following insiders have purchased CMPX shares in the last 24 months: Carl L Gordon ($18,942,311.28), Orbimed Advisors Llc ($1,448,556.72), and Thomas J Schuetz ($968,680.40).

How much insider buying is happening at Compass Therapeutics?

Insiders have purchased a total of 6,286,668 CMPX shares in the last 24 months for a total of $21,359,548.40 bought.

Which Compass Therapeutics insiders have been selling company stock?

The following insider sold CMPX shares in the last 24 months: Vered Bisker-Leib ($62,561.23).

How much insider selling is happening at Compass Therapeutics?

Insiders have sold a total of 14,931 Compass Therapeutics shares in the last 24 months for a total of $62,561.23 sold.

This page (NASDAQ:CMPX) was last updated on 4/1/2023 by MarketBeat.com Staff